Table 2.
Patients reporting any treatment emergent toxicities.
| Grade | 1 | 2 | 3 | 4 | 5 |
|---|---|---|---|---|---|
| Arthralgia | 2 (6%) | ||||
| Anorexia | 8 (24%) | 2 (6%) | 1 (3%) | ||
| Nausea | 8 (24%) | 2 (6%) | |||
| Diarrhea | 7 (21%) | 3 (9%) | |||
| Dysgeusia | 4 (12%) | 2 (6%) | |||
| Fatigue | 6 (18%) | 9 (27%) | 2 (6%) | ||
| Hypothyroidism | 1 (3%) | 1 (3%) | |||
| Rash | 2 (6%) | ||||
| AST/ALT | 2 (6%) | 1 (3%) | 3 (9%) | ||
| Thrombocytopenia | 6 (18%) | 4 (12%) | 2 (6%) | ||
| Neutropenia | 2 (6%) | 1 (3%) | |||
| Hypophosphatemia | 1 (3%) | 1 (3%) | |||
| Hyponatremia | 2 (6%) | ||||
| Elevated creatinine | 4 (12%) | 2 (6%) | |||
| Pneumonitis | 1 (3%) | ||||
| Stroke | 1 (3%) | ||||
| Colitis^ | 1 (3%) |
^>30 days after removal from study.